...
首页> 外文期刊>Vaccine >Topical delivery of imiquimod to a mouse model as a novel adjuvant for human immunodeficiency virus (HIV) DNA
【24h】

Topical delivery of imiquimod to a mouse model as a novel adjuvant for human immunodeficiency virus (HIV) DNA

机译:将咪喹莫特局部递送至小鼠模型作为人类免疫缺陷病毒(HIV)DNA的新型佐剂

获取原文
获取原文并翻译 | 示例
           

摘要

We evaluated the compound imiquimod as a possible adjuvant for DNA immunization against human immunodeficiency virus (HIV). We found that gene-gun epidermal delivery of the DNA in combination with imiquimod resulted in the strongest HIV specific immune responses. The effect of imiquimod was further compared to that of recombinant granulocyte macrophage-colony stimulating factor (GM-CSF), a known DNA vaccine adjuvant. Both adjuvants were able to enhance the immune responses induced by the HIV-1 genes alone. The delivery of an adjuvant as a topical cream rather than through injections has a clear clinical benefit. We show for the first time that imiquimod can act as an adjuvant for DNA vaccination
机译:我们评估了化合物咪喹莫特作为抗人免疫缺陷病毒(HIV)的DNA免疫的可能佐剂。我们发现与咪喹莫特组合使用的基因枪表皮传递的DNA导致最强的HIV特异性免疫反应。将咪喹莫特的作用与已知的DNA疫苗佐剂重组粒细胞巨噬细胞集落刺激因子(GM-CSF)进行了比较。两种佐剂均能够增强仅由HIV-1基因诱导的免疫应答。佐剂作为局部乳膏而不是通过注射给药具有明显的临床益处。我们首次证明咪喹莫特可以作为DNA疫苗的佐剂

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号